Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,690 | 68 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $526.45 | 18 | $0 (2024) |
| Sight Sciences, Inc. | $461.94 | 5 | $0 (2024) |
| Alcon Vision LLC | $278.64 | 7 | $0 (2024) |
| Glaukos Corporation | $264.90 | 5 | $0 (2023) |
| BIOTISSUE HOLDINGS INC. | $257.15 | 5 | $0 (2024) |
| NEW WORLD MEDICAL,INC. | $252.37 | 3 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $147.70 | 6 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $145.85 | 7 | $0 (2024) |
| Tarsus Pharmaceuticals, Inc. | $133.08 | 6 | $0 (2024) |
| Oyster Point Pharma, Inc. | $70.61 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,527 | 47 | BIOTISSUE HOLDINGS INC. ($257.15) |
| 2023 | $1,082 | 20 | AbbVie Inc. ($309.30) |
| 2022 | $80.68 | 1 | GLAUKOS CORPORATION ($80.68) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Ophthalmology | ||||||
| 12/18/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Ophthalmology | ||||||
| 11/13/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: Ophthalmology | ||||||
| 10/29/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Ophthalmology | ||||||
| 10/28/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $32.04 | General |
| Category: SOLUTION/ DROPS | ||||||
| 10/23/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: EYE CARE | ||||||
| 10/13/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $24.10 | General |
| 10/07/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: EYE CARE | ||||||
| 10/07/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Ophthalmology | ||||||
| 10/03/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $8.51 | General |
| Category: EYE CARE | ||||||
| 10/02/2024 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Ophthalmology | ||||||
| 09/11/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Dry eyes | ||||||
| 09/09/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $8.44 | General |
| Category: EYE CARE | ||||||
| 09/02/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $82.82 | General |
| 08/28/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Ophthalmology | ||||||
| 07/31/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/31/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/16/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Ophthalmology | ||||||
| 07/08/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: EYE CARE | ||||||
| 06/28/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Ophthalmology | ||||||
| 06/25/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $145.37 | General |
| Category: Ophthalmology | ||||||
| 06/20/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/18/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: Ophthalmology | ||||||
| 06/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Ophthalmology | ||||||
| 06/05/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: EYE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 511 | 553 | $182,035 | $56,703 |
| 2022 | 1 | 13 | 15 | $2,511 | $464.85 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 28 | 39 | $53,040 | $16,528 | 31.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 87 | 87 | $33,060 | $11,654 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 65 | $19,540 | $7,227 | 37.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 36 | 36 | $11,340 | $4,704 | 41.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 54 | $11,000 | $4,277 | 38.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 32 | 32 | $9,440 | $3,269 | 34.6% |
| 92133 | Imaging of optic nerve | Office | 2023 | 80 | 81 | $7,695 | $2,631 | 34.2% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 58 | 66 | $18,000 | $2,530 | 14.1% |
| 66170 | Creation of eye fluid drainage tract for treatment of glaucoma | Facility | 2023 | 11 | 11 | $9,900 | $1,686 | 17.0% |
| 92134 | Imaging of retina | Office | 2023 | 30 | 30 | $3,000 | $1,054 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 13 | 16 | $4,308 | $559.30 | 13.0% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 14 | 16 | $912.00 | $392.48 | 43.0% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 20 | 20 | $800.00 | $189.56 | 23.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 13 | 15 | $2,511 | $464.85 | 18.5% |
About Dr. Aseef Ahmed, DO
Dr. Aseef Ahmed, DO is a Glaucoma Specialist healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2018. The National Provider Identifier (NPI) number assigned to this provider is 1649769233.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aseef Ahmed, DO has received a total of $2,690 in payments from pharmaceutical and medical device companies, with $1,527 received in 2024. These payments were reported across 68 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,690).
As a Medicare-enrolled provider, Ahmed has provided services to 524 Medicare beneficiaries, totaling 568 services with total Medicare billing of $57,168. Data is available for 2 years (2022–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Glaucoma Specialist
- Location Boston, MA
- Active Since 05/09/2018
- Last Updated 06/22/2023
- Taxonomy Code 207WX0009X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1649769233
Products in Payments
- OMNI SURGICAL SYSTEM (Device) $461.94
- DURYSTA (Drug) $310.39
- Rocklatan (Drug) $254.98
- Kahook Dual Blade (Device) $170.67
- Cequa (Drug) $147.70
- XDEMVY (Drug) $133.08
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $111.20
- LUMIGAN (Drug) $104.86
- ISTENT INJECT W (Device) $80.68
- TYRVAYA (Drug) $70.61
- RXSIGHT CONTACT LENS (Device) $65.34
- VYZULTA (Drug) $63.17
- LENSAR LASER SYSTEM (Device) $54.25
- XIIDRA (Drug) $43.88
- MIEBO (Drug) $38.80
- OXERVATE (Drug) $32.04
- EYSUVIS (Drug) $23.66
- PHOTREXA CROSS-LINKING KIT (Drug) $20.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Glaucoma Specialist Doctors in Boston
Sarwat Salim, Md, MD
Glaucoma Specialist — Payments: $95,457
Dr. David Sola-Del Valle, Md, MD
Glaucoma Specialist — Payments: $32,765
Dr. Michael Giovingo, M.d, M.D
Glaucoma Specialist — Payments: $22,117
David Smits, Md, MD
Glaucoma Specialist — Payments: $3,020
Dr. Deidrya Jackson, Md Mph, MD MPH
Glaucoma Specialist — Payments: $606.55
Dr. Mohammad-Hossein Mohammad-Shahi, Md, MD
Glaucoma Specialist — Payments: $152.28